After the intraperitoneal injection of TMZ (2 mg/kg) into the above groups, the tumour volume decreased after HIF1α or HIF2α knockout, and the smallest tumour volume was observed in the group with simultaneous HIF1α and HIF2α knockout. This evidence concerns the gene HIF1A and neoplasm.